The involvement of β-amyloid in the etiology of Alzheimer disease

Brain and Nerve

Volumn 62, Issue 7, 2010, Pages 691-699

  Tomiyama, Takami ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

A fibril; A oligomer; Dementia; Senile plaque; Synapse

Indexed keywords

AMYLOID BETA DERIVED DIFFUSIBLE LIGAND; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CALCIUM ION; LIGAND; N METHYL DEXTRO ASPARTIC ACID; OLIGOMER; PITTSBURGH COMPOUND B; UNCLASSIFIED DRUG; AMYLOID;

ALZHEIMER DISEASE; ARTICLE; DEMENTIA; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPATHOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; POSITRON EMISSION TOMOGRAPHY; SENILE PLAQUE; SYNAPSE; AMYLOID PLAQUE; BRAIN; GENETICS; METABOLISM; MUTATION; NERVE CELL; PATHOLOGY; SOLUBILITY; TOXICITY;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; HUMANS; MUTATION; NEUROFIBRILLARY TANGLES; NEURONS; SENILE PLAQUES; SOLUBILITY; SYNAPSES; AMYLOID BETA-PEPTIDES; PLAQUE, AMYLOID;

EID: 77955367175     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185, 1992
2. Klein WL, Krafft GA, Finch CE: Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 24: 219-224, 2001
3. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 298: 789-791, 2002
4. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, et al: β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741, 1999 (Pubitemid 129515714)
5. Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, et al: The role of presenilin cofactors in the γ-secretase complex. Nature 422: 438-441, 2003 (Pubitemid 36411397)
6. Kimberly WT, Zheng JB, Guénette SY, Selkoe DJ: The intracellular domain of the β-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 276: 40288-40292, 2001 (Pubitemid 37391451)
7. Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, et al: Longer forms of amyloid β protein: implications for the mechanism of intramembrane cleavage by γ-secretase. J Neurosci 25: 436-445, 2005
8. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, et al: Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6: 143-150, 2000 (Pubitemid 30082357)
9. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, et al: Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J Biol Chem 273: 32730-32738, 1998 (Pubitemid 28557658)
10. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, et al: LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 43: 333-344, 2004 (Pubitemid 39061126)
11. Lorenzo A, Yankner BA: β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A 91: 12243-12247, 1994 (Pubitemid 24368641)
12. Jarrett JT, Lansbury PT Jr: Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058, 1993
13. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, et al: Visualization of Aβ42(43) and Aβ340 in senile plaques with end-specific Aβ monoclonale: evidence that an initially deposited species is Aβ342(43). Neuron 13: 45-53, 1994
14. Tanzi RE, Bertram L: Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120: 545-555, 2005
15. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriëre A, et al: APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38: 24-26, 2006
16. Yang LB, Lindholm K, Yan R, Citron M, Xia W, et al: Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9: 3-4, 2003 (Pubitemid 36098241)
17. Yasojima K, Akiyama H, McGeer EG, McGeer PL: Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci Lett 297: 97-100, 2001
18. Zhao Z, Xiang Z, Haroutunian V, Buxbaum JD, Stetka B, et al: Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease. Neurobiol Aging 28: 824-830, 2007 (Pubitemid 46589743)
19. Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, et al: Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 162: 313-319, 2003 (Pubitemid 36042013)
20. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, et al: ApoE promotes the proteolytic degradation of Aβ. Neuron 58: 681-693, 2008
21. Deane R, Sagare A, Hamm K, Parisi M, Lane S, et al: apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain. J Clin Invest 118: 4002-4013, 2008
22. N3(PE), in senile plaques. Neuron 14: 457-466, 1995
23. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al: Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539, 2002 (Pubitemid 34288854)
24. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, et al: Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nature Neurosci 8: 79-84, 2005
25. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, et al: Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27: 2866-2875, 2007 (Pubitemid 46438992)
26. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, et al: Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837-842, 2008
27. Townsend M, Mehta T, Selkoe DJ: Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282: 33305-33312, 2007 (Pubitemid 350159548)
28. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, et al: Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62: 788-801, 2009
29. 1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95: 6448-6453, 1998 (Pubitemid 28249033)
30. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, et al: A specific amyloid-β protein assembly in the brain impairs memory. Nature 440: 352-357, 2006
31. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, et al: Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27: 796-807, 2007
32. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, et al: Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol Aging 29: 1334-1347, 2008 (Pubitemid 351970596)
33. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, et al: Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 100: 10417-10422, 2003
34. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, et al: Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282: 11590-11601, 2007
35. Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, et al: Amyloid β oligomers induce impairment of neuronal insulin receptors. FASEB J 22: 246-260, 2008
36. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB: Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 272: 22364-22372, 1997
37. Quist A, Doudevski I, Lin H, Azimova R, Ng D, et al: Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102: 10427-10432, 2005 (Pubitemid 41061570)
38. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, et al: Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284: 4230-4237, 2009
39. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, et al: Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model. Nat Neurosci 5: 452-457, 2002
40. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, et al: Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372: 216-223, 2008 (Pubitemid 351978111)
41. Martins IC, Kuperstein I, Wilkinson H, Maes E, Vanbrabant M, et al: Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J 27: 224-233, 2008
42. Gaspar RC, Villarreal SA, Bowles N, Hepler RW, Joyce JG, et al: Oligomers of β-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model. Exp Neurol doi: 10.1016/j.expneurol.2009.09.001, 2009
43. Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, et al: A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia. Ann Neurol 63: 377-387, 2008 (Pubitemid 351499867)
44. Tomiyama T, Matsuyama S, Iso H, Umeda T, Takuma H, et al; A mouse model of amyloid β oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J Neurosci 30: 4845-4856, 2010